C92.31Billable
Myeloid sarcoma, in remission
- Chapter
- 2. Neoplasms
- Category
- C92
- Effective date
- October 1, 2026
Related codes in category C92
C92Myeloid leukemiaC92.0Acute myeloblastic leukemiaC92.00Acute myeloblastic leukemia, not having achieved remissionYesC92.01Acute myeloblastic leukemia, in remissionYesC92.02Acute myeloblastic leukemia, in relapseYesC92.1Chronic myeloid leukemia, BCR/ABL-positiveC92.10Chronic myeloid leuk, BCR/ABL-positive, not achieve remisYesC92.11Chronic myeloid leukemia, BCR/ABL-positive, in remissionYesC92.12Chronic myeloid leukemia, BCR/ABL-positive, in relapseYesC92.2Atypical chronic myeloid leukemia, BCR/ABL-negativeC92.20Atyp chronic myeloid leuk, BCR/ABL-neg, not achieve remisYesC92.21Atypical chronic myeloid leukemia, BCR/ABL-neg, in remissionYes
Frequently asked questions
What is ICD-10 code C92.31?
C92.31 is an ICD-10-CM diagnosis code for Myeloid sarcoma, in remission.
Is C92.31 a billable code?
Yes. C92.31 is billable and specific enough to be used on a claim.
What ICD-10-CM chapter is C92.31 in?
C92.31 falls under Chapter 2: Neoplasms.
When did C92.31 become effective?
C92.31 has been effective since October 1, 2026, per the CMS/CDC ICD-10-CM annual release.
What other codes are related to C92.31?
C92.31 belongs to category C92, which includes 12 other codes — see the related codes list on this page.
ICD-10-CM data maintained by CDC/CMS (public domain). Always verify codes with authoritative sources before making coding or billing decisions.